{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:50:35Z","timestamp":1793836235467,"version":"4.6.1"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","croh-online.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.critrevonc.2017.02.011","type":"journal-article","created":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T22:00:22Z","timestamp":1487368822000},"page":"103-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Interferon induced thrombotic microangiopathy (TMA): Analysis and concise review"],"prefix":"10.1016","volume":"112","author":[{"given":"Ajay","family":"Kundra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen Chin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2017.02.011_bib0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF02989643","article-title":"The role of interferon as maintenance therapy in malignant lymphoma","volume":"14","author":"Agustin Avil\u00e9s","year":"1997","journal-title":"Med. Oncol."},{"key":"10.1016\/j.critrevonc.2017.02.011_bib0010","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/ndt\/16.4.846","article-title":"Renal thrombotic microangiopathy induced by interferon\u00e9-\u03b1","volume":"16","author":"Badid","year":"2001","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.critrevonc.2017.02.011_bib0015","first-page":"S227","article-title":"A case of thrombotic microangiopathy associated with subcutaneous beta-1a-interferon therapy","volume":"17","author":"Bensa","year":"2011","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.critrevonc.2017.02.011_bib0020","first-page":"91","article-title":"Thrombotic thrombocytopenic purpura with unusual 33 recurrences: a case report","volume":"43","author":"Boctor","year":"2013","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"5","key":"10.1016\/j.critrevonc.2017.02.011_bib0025","doi-asserted-by":"crossref","first-page":"396","DOI":"10.5414\/CN106523","article-title":"Thrombotic microangiopathy induced by long-term interferon-\u03b2 therapy for multiple sclerosis: a case report","volume":"76","author":"Broughton","year":"2011","journal-title":"Clin. Nephrol."},{"issue":"August (2)","key":"10.1016\/j.critrevonc.2017.02.011_bib0030","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/ejh.12306","article-title":"Monocyte-derived dendritic cells from chronic myeloid leukaemia have abnormal maturation and cytoskeletal function that is associated with defective localisation and signalling by normal ABL1 protein","volume":"93","author":"Brown","year":"2014","journal-title":"Eur. J. Haematol."},{"issue":"6","key":"10.1016\/j.critrevonc.2017.02.011_bib0035","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/leu.2015.45","article-title":"Interferon alpha 2 maintenance therapy may enable high rates of treatment discontinuation in chronic myeloid leukemia","volume":"29","author":"Burchert","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2017.02.011_bib0040","first-page":"7","article-title":"Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors","author":"Cortazar","year":"2016","journal-title":"Kidney Int."},{"issue":"December (6)","key":"10.1016\/j.critrevonc.2017.02.011_bib0045","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0168-8278(02)00302-1","article-title":"Cutaneous thrombotic microangiopathy during treatment with alpha-interferon for chronic hepatitis C","volume":"37","author":"Creput","year":"2002","journal-title":"J. Hepatol."},{"issue":"November (11)","key":"10.1016\/j.critrevonc.2017.02.011_bib0050","first-page":"1039","article-title":"Hemolitic uremic syndrome with hypertransaminasemia following treatment by interferon for chronic myeloid leukemia","volume":"25","author":"Denizon","year":"2001","journal-title":"Gastroenterol. Clin. Biol."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.02.011_bib0055","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1080\/00365520600930685","article-title":"Thrombotic thrombocytopenic purpura with fatal outcome in a patient with chronic hepatitis C treated with pegylated interferon-a\/2b","volume":"42","author":"Deutsch","year":"2007","journal-title":"Scand. J. Gastroenterol."},{"issue":"December (6)","key":"10.1016\/j.critrevonc.2017.02.011_bib0060","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S0168-8278(96)80304-7","article-title":"Immune thrombocytopenia and alpha-interferon therapy","volume":"25","author":"Dourakis","year":"1996","journal-title":"J. Hepatol."},{"key":"10.1016\/j.critrevonc.2017.02.011_bib0065","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy","volume":"358","author":"Eremina","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"April (4)","key":"10.1016\/j.critrevonc.2017.02.011_bib0070","article-title":"Thrombotic microangiopathy (TMA) in a patient treated with antiviral therapy for hepatitis C","volume":"2014","author":"Evans","year":"2014","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.critrevonc.2017.02.011_bib0075","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0168-8278(96)80184-X","article-title":"Investigators of the Italian Association for the Study of the Liver A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon","volume":"24","author":"Fattovich","year":"1996","journal-title":"J. Hepatol."},{"issue":"August","key":"10.1016\/j.critrevonc.2017.02.011_bib0080","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04082","article-title":"Mechanism of action of interferon and ribavirin in treatment of hepatitis C","volume":"436","author":"Feld","year":"2005","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.critrevonc.2017.02.011_bib0085","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/BOR.0b013e32835c7e32","article-title":"Endogenous type I interferon inducers in autoimmune diseases","volume":"25","author":"Finke","year":"2013","journal-title":"Curr. Opin. Rheumatol."},{"issue":"Suppl","key":"10.1016\/j.critrevonc.2017.02.011_bib0090","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/1097-0142(19870201)59:3+<601::AID-CNCR2820591304>3.0.CO;2-J","article-title":"Interferon therapy of non-Hodgkin's lymphoma","volume":"59","author":"Foon","year":"1987","journal-title":"Cancer"},{"issue":"February (1)","key":"10.1016\/j.critrevonc.2017.02.011_bib0095","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1440-1797.2006.00524.x","article-title":"Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myeloid leukaemia","volume":"11","author":"Galesic","year":"2006","journal-title":"Nephrology (Carlton)"},{"issue":"Suppl. 7","key":"10.1016\/j.critrevonc.2017.02.011_bib0100","first-page":"12","article-title":"Clinical trials of alpha-interferon in the treatment of non-Hodgkin's lymphoma","volume":"18","author":"Gaynor","year":"1991","journal-title":"Semin. Oncol."},{"issue":"March 3 Pt. (2)","key":"10.1016\/j.critrevonc.2017.02.011_bib0105","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.lpm.2011.10.026","article-title":"Thrombotic microangiopathic syndromes associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancer","volume":"41","author":"George","year":"2012","journal-title":"Presse Med."},{"issue":"June (2)","key":"10.1016\/j.critrevonc.2017.02.011_bib0110","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ajh.2830460220","article-title":"Recombinant interferon alpha and hemolytic uremic syndrome: cause or coincidence?","volume":"46","author":"Harvey","year":"1994","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.critrevonc.2017.02.011_bib0115","first-page":"1","article-title":"Thrombotic thrombocytopenic purpura (TTP) associated with interferon therapy of hepatitis C","volume":"10","author":"Hepburn","year":"2010","journal-title":"Grand Rounds"},{"issue":"April (6)","key":"10.1016\/j.critrevonc.2017.02.011_bib0120","first-page":"A135","article-title":"Occurrence of a TTP-like syndrome in two women receiving beta interferon therapy for relapsing multiple sclerosis","volume":"52","author":"Herrera","year":"1999","journal-title":"Neurology"},{"issue":"July (1)","key":"10.1016\/j.critrevonc.2017.02.011_bib0125","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0272-6386(97)90575-8","article-title":"Nihei H.Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myelocytic leukemia","volume":"30","author":"Honda","year":"1997","journal-title":"Am. J. Kidney Dis."},{"issue":"March (27)","key":"10.1016\/j.critrevonc.2017.02.011_bib0130","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1056\/NEJMc1316118","article-title":"Thrombotic microangiopathy associated with interferon beta","volume":"370","author":"Hunt","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"October (10)","key":"10.1016\/j.critrevonc.2017.02.011_bib0135","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/ajh.22057","article-title":"Thrombotic microangiopathy complicating pegylated interferon treatment of hepatitis C infection","volume":"86","author":"Iskander","year":"2011","journal-title":"Am. J. Hematol."},{"issue":"4","key":"10.1016\/j.critrevonc.2017.02.011_bib0140","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s005350050139","article-title":"Thrombotic thrombocytopenic purpura developed suddenly during interferon treatment for chronic hepatitis C","volume":"33","author":"Iyoda","year":"1998","journal-title":"J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.critrevonc.2017.02.011_bib0145","first-page":"111","article-title":"Renal thrombotic microangiopathy in patients with chronic myelogenous leukaemia treated with interferon-alpha 2b","volume":"10","author":"Jadoul","year":"1995","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.critrevonc.2017.02.011_bib0150","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13045-014-0072-6","article-title":"T cell immune abnormalities in immune thrombocytopenia","volume":"7","author":"Ji","year":"2014","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.02.011_bib0155","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ajh.10090","article-title":"Multiple sclerosis associated with interferon-alpha therapy for chronic myelogenous leukemia","volume":"70","author":"Kataoka","year":"2002","journal-title":"Am. J. Hematol."},{"issue":"Decemdr (24)","key":"10.1016\/j.critrevonc.2017.02.011_bib0160","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1182\/blood-2016-05-715987","article-title":"Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature","volume":"128","author":"Kavanagh","year":"2016","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.critrevonc.2017.02.011_bib0165","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2165\/11591110-000000000-00000","article-title":"The mechanism of action of interferon-\u03b2 in relapsing multiple sclerosis","volume":"25","author":"Kieseier","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.critrevonc.2017.02.011_bib0170","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/leu.2015.326","article-title":"Interferon-alpha for the therapy of myeloproliferative neoplasms: targeting the malignant clone","volume":"30","author":"Kiladjian","year":"2016","journal-title":"Leukemia"},{"issue":"8 Suppl","key":"10.1016\/j.critrevonc.2017.02.011_bib0175","first-page":"ECR34","article-title":"M Uemura and Y Fujimura Thrombotic thrombocytopenic purpura associated with pegylated-interferon alpha-2a by an ADAMTS13 inhibitor in a patient with chronic hepatitis C","volume":"91","author":"Kitano","year":"2006","journal-title":"Haematologica"},{"issue":"July (7)","key":"10.1016\/j.critrevonc.2017.02.011_bib0180","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2169\/naika.86.1259","article-title":"Case of chronic myelogenous leukemia with hemolytic-uremic-syndrome like kidney during long-term interferon-alpha therapy","volume":"86","author":"Kobayashi","year":"1997","journal-title":"Nihon Naika Gakkai Zasshi"},{"issue":"8","key":"10.1016\/j.critrevonc.2017.02.011_bib0185","doi-asserted-by":"crossref","first-page":"e23022","DOI":"10.1371\/journal.pone.0023022","article-title":"Chronic myeloid leukemia patients in prolonged remission following interferon-\u03b1 monotherapy have distinct cytokine and oligoclonal lymphocyte profile","volume":"6","author":"Kreutzman","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2017.02.011_bib0190","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000040993","article-title":"Thrombotic thrombocytopenic purpura during interferon alpha treatment for chronic myelogenous leukemia","volume":"102","author":"Lacotte","year":"1999","journal-title":"Acta Haematol."},{"issue":"11","key":"10.1016\/j.critrevonc.2017.02.011_bib0195","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.lpm.2010.04.016","article-title":"Thrombotic thrombocytopenic purpura mediated by an ADAMTS13-inhibitor related to a treatment with peglyated-interferon alpha-2a and ribavarine in a patient with chronic hepatitis C","volume":"39","author":"Lambot","year":"2010","journal-title":"La Presse m\u00e9dicale"},{"key":"10.1016\/j.critrevonc.2017.02.011_bib0200","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1177\/1352458514523692","article-title":"Thrombotic Thrombocytopenic Purpura- Hemolytic Uremic Syndrome in relapsing-remitting multiple sclerosis patients on high dose interferon \u03b2","volume":"13","author":"Larochelle","year":"2014","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.critrevonc.2017.02.011_bib0205","article-title":"Renal thrombotic microangiopathy induced by \u03b2-interferon","volume":"4","author":"Li Cavoli","year":"2011","journal-title":"NDT Plus"},{"issue":"May (1)","key":"10.1016\/j.critrevonc.2017.02.011_bib0210","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/ajh.2830490124","article-title":"CML may not be part of HUS","volume":"49","author":"Lipton","year":"1995","journal-title":"Am. J. Hematol."},{"issue":"September (9)","key":"10.1016\/j.critrevonc.2017.02.011_bib0215","first-page":"710","article-title":"A case report of interferon-induced autoimmune thrombocytopenic purpura","volume":"21","author":"Ma","year":"2013","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"July (1)","key":"10.1016\/j.critrevonc.2017.02.011_bib0220","first-page":"E5","article-title":"Renal thrombotic microangiopathy associated with interferon-alpha treatment of chronic myeloid leukemia","volume":"36","author":"Magee","year":"2000","journal-title":"Am. J. Kidney Dis."},{"issue":"August (7)","key":"10.1016\/j.critrevonc.2017.02.011_bib0225","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2147\/DDDT.S42138","article-title":"Renal thrombotic microangiopathy caused by interferon beta-1a treatment for multiple sclerosis","volume":"7","author":"Mahe","year":"2013","journal-title":"Drug Des. Dev. Ther."},{"issue":"4","key":"10.1016\/j.critrevonc.2017.02.011_bib0230","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.21146","article-title":"The clinical and physiological spectrum of interferon-alpha induced thyroiditis. Toward a new classification","volume":"43","author":"Mandac","year":"2006","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.critrevonc.2017.02.011_bib0235","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.revmed.2013.03.003","article-title":"Thrombotic thrombocytopenic purpura associated with interferon therapy in a HIV and HCV co-infected woman","volume":"34","author":"Michaux","year":"2013","journal-title":"Revue de M\u00e9decine Interne"},{"issue":"11","key":"10.1016\/j.critrevonc.2017.02.011_bib0240","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1177\/1352458512441272","article-title":"Arterial hypertension induced by interferon beta 1b in a patient with multiple sclerosis","volume":"18","author":"Modrego","year":"2012","journal-title":"Mult. Scler. J."},{"issue":"July (7)","key":"10.1016\/j.critrevonc.2017.02.011_bib0245","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s00415-013-6961-8","article-title":"Hemolytic uremic syndrome: an unusual complication of interferon-(treatment in a MS patient","volume":"260","author":"Nerrant","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.critrevonc.2017.02.011_bib0250","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrneph.2012.195","article-title":"STEC-HUS, atypical HUS and TTP are all diseases of complement activation","volume":"8","author":"Noris","year":"2012","journal-title":"Nat. Rev. Nephrol."},{"issue":"March (3)","key":"10.1016\/j.critrevonc.2017.02.011_bib0255","first-page":"E10","article-title":"Withdrawal of interferon-alpha results in prompt resolution of thrombocytopenia and hemolysis but not renal failure in hemolytic uremic syndrome caused by interferon-alpha","volume":"41","author":"Ohashi","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.critrevonc.2017.02.011_bib0260","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/IJNRD.S30194","article-title":"Thrombotic microangiopathy associated with use of interferon-beta","volume":"5","author":"Olea","year":"2012","journal-title":"Int. J. Nephrol. Renovasc. Dis."},{"key":"10.1016\/j.critrevonc.2017.02.011_bib0265","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11255-013-0401-7","article-title":"Thrombotic microangiopathy due to acquired ADAMTS13 deficiency in a patient receiving interferon-beta treatment for multiple sclerosis","volume":"46","author":"Orvain","year":"2014","journal-title":"Int. Urol. Nephrol."},{"issue":"9","key":"10.1016\/j.critrevonc.2017.02.011_bib0270","first-page":"1781","article-title":"Potential Role for Antiphospholipid Antibodies in Renal Thrombotic Microangiopathy Induced by Interferon-alpha","volume":"10","author":"Piette","year":"1995","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.critrevonc.2017.02.011_bib0275","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0953-6205(00)00083-2","article-title":"Thrombotic microangiopathy","volume":"11","author":"Pisoni","year":"2000","journal-title":"Eur. J. Intern. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2017.02.011_bib0280","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4081\/hr.2013.e2","article-title":"Thrombotic thrombocytopenic purpura in a patient with interferon treated hepatitis C successfully treated with rituximab","volume":"5","author":"Poddar","year":"2013","journal-title":"Hematol. Rep."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.02.011_bib0285","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/ndt\/gfg537","article-title":"Thrombotic microangiopathy in a patient with Sezary syndrome treated with interferon-\u03b1","volume":"19","author":"Politou","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.critrevonc.2017.02.011_bib0290","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1182\/blood-2013-02-483412","article-title":"Presenting ADAMTS13 on a TTP-associated MHC","volume":"121","author":"Pratt","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.critrevonc.2017.02.011_bib0295","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/BOR.0b013e32835c7e32","article-title":"The interferon signature in autoimmune diseases","volume":"25","author":"R\u00f6nnblom","year":"2013","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.critrevonc.2017.02.011_bib0300","first-page":"505","article-title":"The type I interferon system in the etiopathogenesis of autoimmune diseases","volume":"90","author":"R\u00f6nnblom","year":"2012","journal-title":"Immunol. Cell Biol."},{"issue":"4","key":"10.1016\/j.critrevonc.2017.02.011_bib0305","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000040905","article-title":"Ben-Bassat I.Thrombotic thrombocytopenic purpura complicating chronic myelogenous leukemia treated with interferon-alpha. A report of two successfully treated patients","volume":"100","author":"Rachmani","year":"1998","journal-title":"Acta Haematol."},{"key":"10.1016\/j.critrevonc.2017.02.011_bib0310","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1002\/(SICI)1097-0142(19990615)85:12<2583::AID-CNCR14>3.0.CO;2-#","article-title":"Thrombotic microangiopathy associated with interferon therapy for patients with chronic myelogenous leukemia","volume":"85","author":"Ravandi-Kashani","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2017.02.011_bib0315","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMcp1006613","article-title":"Chronic hepatitis C infection","volume":"364","author":"Rosen Hugo","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"December (1)","key":"10.1016\/j.critrevonc.2017.02.011_bib0320","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.clineuro.2013.09.027","article-title":"Interferons beta have vasoconstrictive and procoagulant effects: a woman who developed livedo reticularis and Raynaud phenomenon in association with interferon beta treatment for multiple sclerosis","volume":"115","author":"Rot","year":"2013","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.02.011_bib0325","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.gcb.2007.12.019","article-title":"Thrombotic thrombocytopenic purpura complicating interferon therapy in chronic C hepatitis","volume":"32","author":"Sall\u00e9e","year":"2008","journal-title":"Gastroenterol. Clin. Biol."},{"issue":"November (3)","key":"10.1016\/j.critrevonc.2017.02.011_bib0330","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/ajh.2830470332","article-title":"Hemolytic-uremic syndrome in a patient with chronic myelogenous leukemia treated with interferon alpha","volume":"47","author":"Schlaifer","year":"1994","journal-title":"Am. J. Hematol."},{"issue":"7","key":"10.1016\/j.critrevonc.2017.02.011_bib0335","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0025-7753(07)72559-9","article-title":"Thrombotic thrombocytopenic purpura during treatment with interpheron","volume":"128","author":"Serrano","year":"2007","journal-title":"Med. Clin. (Barc.)"},{"issue":"11","key":"10.1016\/j.critrevonc.2017.02.011_bib0340","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.7326\/0003-4819-119-11-199312010-00006","article-title":"Interferon-2b: a new treatment for polycythemia vera","volume":"119","author":"Silver","year":"1993","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.critrevonc.2017.02.011_bib0345","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3109\/08860229309054974","article-title":"Hemolytic-uremic syndrome during recombinant alpha-interferon treatment for hairy cell leukemia","volume":"15","author":"Stratta","year":"1993","journal-title":"Ren. Fail."},{"key":"10.1016\/j.critrevonc.2017.02.011_bib0350","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1055\/s-2007-996123","article-title":"Interferon-alpha therapy in polycythemia vera and essential thrombocythemia","volume":"23","author":"Tefferi","year":"1997","journal-title":"Semin. Thromb. Hemost."},{"issue":"September (1)","key":"10.1016\/j.critrevonc.2017.02.011_bib0355","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000045147","article-title":"Hemolytic uremic syndrome associated with beta-interferon therapy for chronic hepatitis C","volume":"80","author":"Ubara","year":"1998","journal-title":"Nephron"},{"issue":"4","key":"10.1016\/j.critrevonc.2017.02.011_bib0360","first-page":"349","article-title":"Marco Prinz Endogenous, or therapeutically induced, type I interferon responses differentially modulate Th1\/Th17-mediated autoimmunity in the CNS","volume":"42","author":"Ulrich Kalinke and","year":"2009","journal-title":"Autoimmunity"},{"key":"10.1016\/j.critrevonc.2017.02.011_bib0365","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1093\/ndt\/14.10.2469","article-title":"Thrombotic microangiopathy in a patient with chronic myelocytic leukaemia treated with \u03b1-interferon","author":"Vacher-Coponat","year":"1999","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.critrevonc.2017.02.011_bib0370","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.msard.2013.12.007","article-title":"Thrombotic microangiopathy in Interferon Beta treated multiple sclerosis patients: review of literature and report of two new cases","volume":"3","author":"Vosoughi","year":"2014","journal-title":"Multiple Scler. Relat. Disord. Mayvol"},{"key":"10.1016\/j.critrevonc.2017.02.011_bib0375","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood-2007-12-125906","article-title":"Interferon-\u03b12b\u2013induced thrombocytopenia is caused by inhibition of platelet production but not proliferation and endomitosis in human megakaryocytes","volume":"112","author":"Yamane","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2017.02.011_bib0380","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40364-015-0045-0","article-title":"Biomarkers for immune thrombocytopenia","volume":"3","author":"Yu","year":"2015","journal-title":"Biomark. Res."},{"issue":"July (4)","key":"10.1016\/j.critrevonc.2017.02.011_bib0385","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00005792-200207000-00008","article-title":"Alpha-interferon-associated thrombotic microangiopathy: a clinicopathologic study of 8 patients and review of literature","volume":"81","author":"Zuber","year":"2002","journal-title":"Medicine (Baltimore)"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842817300793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842817300793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T22:39:46Z","timestamp":1538779186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842817300793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":77,"alternative-id":["S1040842817300793"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2017.02.011","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon induced thrombotic microangiopathy (TMA): Analysis and concise review","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2017.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}